Early immunomodulatory effects of linezolid in a human whole blood endotoxin model

International Journal of Clinical Pharmacology and Therapeutics

Volumn 48, Issue 7, 2010, Pages 419-424

  Lambers, C ^a   Burian, B ^a   Binder, P ^a   Ankersmit, H J ^a   Wagner, C ^a   Muller M ^a   Zeitlinger, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytokines; Linezolid; Sepsis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LINEZOLID; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INCUBATION TIME; MALE; NORMAL HUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SUPERNATANT; VOLUNTEER;

EID: 77954895208     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP48419     Document Type: Article

References (15)

1. Behre G, Schedel I, Nentwig B, Wörmann B, Essink M et al. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob Agents Chemother. 1992; 36: 2139-2146.
2. Brown MA, Jones WK. NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci. 2004; 9: 1201-1217. (Pubitemid 39060836)
3. Dalhoff A, Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis. 2003; 3: 359-371.
4. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med Nov. 2002; 166: 197-1205. (Pubitemid 35222596)
5. Garcia-Roca P, Mancilla-Ramirez J, Santos-Segura A, Fernández- Avilés M, Calderon-Jaimes E. Linezolid diminishes inflammatory cytokine production from human peripheral blood mononuclear cells. Arch Med Res Jan. 2006; 37: 31-35. (Pubitemid 41727888)
6. Gómez J, García-Vázquez E, Baños R, Canteras M, Ruiz J et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis Apr. 2007; 26: 239-245. (Pubitemid 46572024)
7. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348: 138-150.
8. Houck PM, BratzlerDW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004; 164: 637-644. (Pubitemid 38392978)
9. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34: 1589-1596. (Pubitemid 43810035)
10. Kushiya K, Nakagawa S, Taneike I, Iwakura N, Imanishi K et al. Inhibitory effect of antimicrobial agents and anisodamine on the staphylococcalsuper- antigenic toxin-induced overproduction of proinflammatory cytokines by human peripheral blood mononuclear cells. J Infect Chemother Aug. 2005; 11: 192-195. (Pubitemid 41216451)
11. MacGowan AP. Pharmacokinetic and pharmacodynamic profile of Linezolid in healthy volunteers and patients with Gram-positive infections. J Antimicrob Chemother. 2003; 51 (Suppl): 17-25.
12. Morikawa K, Watabe H, Araake M, Morikawa Sl. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother Jun. 1996; 40: 1366-1370. (Pubitemid 26000565)
13. Perry CM, Jarvis B. Linezolid-AReview of its Use in the Management of Serious Gram-Positive Infections. Drugs. 2001; 61: 525-551. (Pubitemid 32368068)
14. Shih JC, Chen K, Ridd MJ. Monoamine oxidase: from genes to behaviour. Annu. Rev. Neurosci. 1999; 22: 197-217.
15. Vega A, Chacón P, Montese J. A new role for monoamine oxidases in the modulation of macrophage-inducible nitric oxide synthase gene expression. J Leukoc Biol. 2004; 75: 1093-1101. (Pubitemid 38720652)